secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2022-10-27T23:59:59+00:00
Accession:  0001493152-22-029686
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GBS Inc. changes name to Intelligent Bio Solutions; appoints Harry Simeonidis as CEO
--------------------------------------------------------------------------------

- Company name changed from GBS Inc. to Intelligent Bio Solutions Inc.; effective Oct 26, 2022.
- Nasdaq ticker changes from GBS to INBS effective Oct 27, 2022.
- Harry Simeonidis appointed President and CEO, succeeding Steven Boyages who remains Chairman.
- David Jenkins and Jason Isenberg appointed to Board of Directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315222029686/0001493152-22-029686-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315222029686/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-029686

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer